Pretreatment NPLH as a Potential Predictor of Pathologic Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Simple blood count ratios predict whether patients will respond to chemotherapy for bladder cancer, enabling personalized planning.
Pretreatment neutrophil-to-platelet-to-lymphocyte-to-hemoglobin (NPLH) ratio derived from CBC parameters predicts pathologic complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- retrospective cohort
- Category
- cbc_diagnostics_ml
- Maturity
- Validated
- Journal
- Ann Surg Oncol
Why it surfaced
CBC-derived NPLH ratio as a pCR predictor in bladder cancer—marginally relevant to CBC diagnostics ML topic as it uses derived indices rather than ML.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.